C92.0 Acute myeloblastic leukemia

⚠ Non-Billable ICD-10-CM 2026
Open C92.0 in Web App →

The ICD-10-CM code for Acute myeloblastic leukemia is C92.0 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
Category C92
41 codes (30 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C92.0:

  • Leukemia, leukemic › acute myeloid, NOS
  • Leukemia, leukemic › acute myeloblastic (minimal differentiation) (with maturation)
  • Leukemia, leukemic › AML (1/ETO) (M0) (M1) (M2) (without a FAB classification)
  • Myelosis › acute
  • Leukemia, leukemic › myeloid › acute
Excludes1
Not coded here. These conditions should NOT be coded together with C92.0.
  • acute exacerbation of chronic myeloid leukemia (C92.10)
  • refractory anemia with excess of blasts not in transformation (D46.2-)

Inclusion Terms

  • Acute myeloblastic leukemia, minimal differentiation
  • Acute myeloblastic leukemia (with maturation)
  • Acute myeloblastic leukemia 1/ETO
  • Acute myeloblastic leukemia M0
  • Acute myeloblastic leukemia M1
  • Acute myeloblastic leukemia M2
  • Acute myeloblastic leukemia with t(8;21)
  • Acute myeloblastic leukemia (without a FAB classification) NOS
  • Refractory anemia with excess blasts in transformation [RAEB T]

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Parent Code

C92 Myeloid leukemia

More Specific Codes

C92.00 Acute myeloblastic leukemia, not having achieved remission C92.01 Acute myeloblastic leukemia, in remission C92.02 Acute myeloblastic leukemia, in relapse

Related Codes in C92

C92 Myeloid leukemia C92.00 Acute myeloblastic leukemia, not having achieved remission C92.01 Acute myeloblastic leukemia, in remission C92.02 Acute myeloblastic leukemia, in relapse C92.1 Chronic myeloid leukemia, BCR/ABL-positive C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negative C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse C92.3 Myeloid sarcoma C92.30 Myeloid sarcoma, not having achieved remission C92.31 Myeloid sarcoma, in remission C92.32 Myeloid sarcoma, in relapse C92.4 Acute promyelocytic leukemia C92.40 Acute promyelocytic leukemia, not having achieved remission C92.41 Acute promyelocytic leukemia, in remission C92.42 Acute promyelocytic leukemia, in relapse
Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial